Psychopharmacology of neurologic disease
Author(s)
Bibliographic Information
Psychopharmacology of neurologic disease
(Handbook of clinical neurology, 3rd ser. ; v. 165)
Elsevier, c2019
- : hbk
Available at 7 libraries
  Aomori
  Iwate
  Miyagi
  Akita
  Yamagata
  Fukushima
  Ibaraki
  Tochigi
  Gunma
  Saitama
  Chiba
  Tokyo
  Kanagawa
  Niigata
  Toyama
  Ishikawa
  Fukui
  Yamanashi
  Nagano
  Gifu
  Shizuoka
  Aichi
  Mie
  Shiga
  Kyoto
  Osaka
  Hyogo
  Nara
  Wakayama
  Tottori
  Shimane
  Okayama
  Hiroshima
  Yamaguchi
  Tokushima
  Kagawa
  Ehime
  Kochi
  Fukuoka
  Saga
  Nagasaki
  Kumamoto
  Oita
  Miyazaki
  Kagoshima
  Okinawa
  Korea
  China
  Thailand
  United Kingdom
  Germany
  Switzerland
  France
  Belgium
  Netherlands
  Sweden
  Norway
  United States of America
Description and Table of Contents
Description
Psychopharmacology of Neurologic Disease, Volume 165 in the Handbook of Clinical Neurology series, provides clinicians with an up-to-date, critical review of the best approaches to treatment of neurologic disease as discussed by experienced clinical investigators. The book is organized into sections on dementia, delirium, movement disorders, hereditary degenerative disease, epilepsy and psychogenic seizures, brain vascular disease, pseudobulbar affect, traumatic brain injury, neuro-oncology, multiple sclerosis and other demyelinating disorders, chronic fatigue syndrome/fibromyalgia, pain, headache, sleep disorders, autoimmune encephalitis/anti- NMDA encephalitis, functional sensory neurologic symptom disorders and neurodevelopmental disorders.
Each of these diagnostic categories has a significant incidence of behavioral symptomatology that is secondary to the neurologic diagnosis that can serve to complicate other therapeutic interventions, alter the course of illness, and cause distress in patients and family caregivers.
Table of Contents
1. Psychiatric manifestations of neurologic disease: Etiology, phenomenology and treatment
2. Behavioral and psychological symptoms in Alzheimer's dementia and vascular dementia
3. Frontotemporal dementia
4. Therapies for prion diseases
5. Behavioral symptomatology and psychopharmacology of Lewy Body dementia
6. Comorbid depression and apathy in HIV-associated neurocognitive disorders in the era of chronic HIV infection
7. Neuropsychiatric aspects of Parkinson disease psychopharmacology: insights from circuit dynamics
8. Tourette disorder and other tic disorders
9. Progressive supranuclear palsy, multiple system atrophy and corticobasal degeneration
10. The psychopharmacology of Huntington disease
11. The psychopharmacology of Wilson disease and other metabolic disorders
12. The psychopharmacology of epilepsy
13. The psychopharmacology of brain vascular disease/post-stroke depression
14. Pseudobulbar affect
15. Psychopharmacology of traumatic brain injury
16. The psychopharmacology of primary and metastatic brain tumors and paraneoplastic syndromes
17. Psychiatric manifestations and psychopharmacology of autoimmune encephalitis: A multidisciplinary approach
18. Psychopharmacology of multiple sclerosis
19. Psychopharmacology of chronic pain
20. Psychopharmacology of headache and its psychiatric comorbidities
21. Psychopharmacology of sleep disorders
22. Sensory neurologic symptom disorders
23. Psychopharmacology of neurobehavioral disorders
24. The psychopharmacology of autism spectrum disorder and Rett syndrome
25. The psychopharmacology of catatonia, neuroleptic malignant syndrome, akathisia, tardive dyskinesia, and dystonia
by "Nielsen BookData"